The Fenlix Motor: A Validated Pipeline for Kinase Inhibitor Selectivity Prediction -- Case I: KRAS G12D in Pancreatic Cancer

Read full text Summarise with VIRAT
Authors: Andrés Sebastián Pirolo
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

We present the Fenlix Motor -- a validated computational pipeline for kinase inhibitor selectivity prediction on accessible hardware, without institutional infrastructure. Named in honor of Felix Pirolo (1940-2019), who died of pancreatic cancer without a targeted therapy available for his mutation. Case I applies the pipeline to KRAS G12D -- present in 40% of pancreatic cancers, with no approved targeted therapy. Screening 13 structural analogues of Sotorasib, analogue B02_3F (single fluorine repositioning from 2,3-difluorophenyl to 3-fluorophenyl) achieves 1.34x improved G12D selectivity over Sotorasib. SMILES: O=C(C=C1CN2CCN(CC2)c3ccc4c(n3)ncc(n4)c5ccc(F)cc5)N1c6ccc(F)cn6 The Fenlix Motor integrates: Contact-Count Proxy (< 1ms), Fibonacci 128 SO(3) rotation sampling (5-10ms, 74% crystallographic convergence across 90 kinases), and selectivity ratio scoring. Part of the Pirolo Computational Docking Series (Papers 1-5). Academic use unrestricted. Commercial use requires written authorization: apirolo@abc.gob.ar

Fields of Study & Subjects

Computational Drug Discovery Methods Protein Kinase Regulation and GTPase Signaling Protein Degradation and Inhibitors

Publication details

Journal / source
Zenodo (CERN European Organization for Nuclear Research)
Publication date
25 March 2026
Language
EN
Document type
Preprint